Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Precision medicine: the rifle vs. shotgun approach to cancer treatment

Hirva Mamdani, MD
Conditions
June 20, 2022
Share
Tweet
Share

Why does one person respond favorably to lung cancer treatment while another does not?

The answer lies in their DNA.

Just 20 years ago, lung cancer was broadly categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Relatively recently, the treatment of NSCLC shifted from chemotherapy as a single treatment option to treatment with precision medicine, which is positively impacting survival rates.

Within the past ten years, researchers and clinicians started to understand biological differences between the two most common subtypes of NSCLC (adenocarcinoma and squamous cell carcinoma), which provided insight into why certain patients had greater success with treatment.

A breakthrough occurred when we discovered specific ‘driver’ gene mutations within the tumor, realized each lung cancer tumor is unique, and started developing medications specifically targeting these mutations. This was the beginning of precision medicine in treating lung cancer.

This discovery allowed us to transition from a “one size fits all” to a “custom made” approach to treatment, and those treatments are working. Treatment with targeted therapies has improved survival and quality of life for patients with advanced non-small-cell lung cancer.

Precision or personalized medicine has many benefits, but the greatest is that it allows patients to receive treatments most likely to work for them while reducing drug toxicity. Essentially, we can use the most effective tools at our disposal rather than deploying them all at once.

So, what’s the bad news?

Testing for common targetable gene mutations/alterations is becoming standard practice in oncology, but many cancer patients do not undergo comprehensive genomic testing. That means targetable mutated genes are often going unnoticed.

Even if a patient has genomic alterations not currently treatable with precision medicine, this advanced testing may provide clinicians with vital insight to rule out which therapies will not work or may potentially negatively impact the efficacy of other treatments. Additionally, while some alterations may not be targetable with an FDA-approved therapy at this time, clinical trials may provide additional future options.

Today, new treatment options are being developed from lifesaving clinical trials regularly. For example, last year, a new drug was approved to target a specific gene abnormality that is present in about 13 percent of lung cancers. This new option provided a fresh path for patients who may have otherwise run out of options. We know even more progress will be made through research and clinical trials.

We are making breakthroughs in cancer treatment every day, and our ability to treat patients more effectively will continue improving as precision medicine advances. I encourage all patients who are diagnosed with cancer to talk with their doctor about individualized treatments and comprehensive genomic testing. I also encourage patients to ask about clinical trials, which truly are the medicine of tomorrow.

We now have capabilities that allow us to better understand why every person responds to cancer differently. More importantly, we are constantly developing new tools that can provide unique treatments for every cancer journey. In time, targeted therapies will move us further toward a world free of cancer.

Hirva Mamdani is the leader of the Thoracic Oncology Multidisciplinary Team, a member of the Phase I Clinical-Pharmacology Program, and director of the Lung Cancer Screening Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, an NCI-designated comprehensive cancer institute with 16 cancer treatment locations in Michigan and Ohio. She can be reached on Twitter @HirvaMamdani and on LinkedIn.

Image credit: Shutterstock.com

Prev

Utilization management is medicine's great conspiracy theory

June 20, 2022 Kevin 0
…
Next

Doctors are not the bad guys

June 20, 2022 Kevin 1
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Utilization management is medicine's great conspiracy theory
Next Post >
Doctors are not the bad guys

Related Posts

  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • What’s barbaric in medicine?

    Lisa Masson, MD, MBA
  • The culture of permission in medicine

    Lauren Joseph
  • How social media can advance humanism in medicine

    Pooja Lakshmin, MD
  • Cancer care costs everyone too much. What can we do about it?

    Andrew Hertler, MD
  • How to avoid treatment you don’t need

    Marshall Allen

More in Conditions

  • The art of pediatrics: Connecting through observation

    Alexander Rakowsky, MD
  • Epigenetics and our inheritance to future generations

    Vishruth Nagam
  • COVID-19 unleashed an ongoing crisis of delirium in hospitals

    Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD
  • Emergency care nightmare: the urgent need for experienced nurses

    Rachel Basham, RN, CCRN
  • Debating the role of psychiatric assessments in medical decisions

    Christian Youssef & Francisco M. Torres, MD
  • 5 things to know about weight from a bariatric surgeon

    Maria Iliakova, MD
  • Most Popular

  • Past Week

    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Inside the grueling life of a surgery intern

      Randall S. Fong, MD | Physician
    • 1 in 5 doctors will become disabled. Are you prepared?

      Amarish Dave, DO | Finance
    • The art of pediatrics: Connecting through observation

      Alexander Rakowsky, MD | Conditions
    • Misinformed claims and the offensiveness of discrediting COVID-19 vaccine development

      Angel Garcia Otano, MD | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
  • Recent Posts

    • The art of pediatrics: Connecting through observation

      Alexander Rakowsky, MD | Conditions
    • Assertiveness in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Epigenetics and our inheritance to future generations

      Vishruth Nagam | Conditions
    • Practicing medicine with conviction

      Arthur Lazarus, MD, MBA | Physician
    • The power of memory in shaping human identity

      Emily F. Peters and Sandeep Jauhar, MD, PhD | Physician
    • How Tratak yoga reshaped my USMLE Step 2 prep

      Dr. Nikita Mehdiratta | Education

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • FDA Relents, Approves Novel Antidepressant After Many Rejections
  • OSHA Comes in for Both Praise and Harsh Criticism at House Hearing
  • New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer
  • Oktoberfest Doctor: Not the Wurst Job You Could Have
  • Blue Shield of California Has Fix for MA Enrollees Worried About Co-Pays

Meeting Coverage

  • New Schizophrenia Treatments Are Coming: Don't Panic
  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • Stopping Medical Misinformation Requires Early Detection
  • AI Has an Image Problem in Healthcare, Expert Says
  • Want Better Health Outcomes? Check Out What Other Countries Do
  • Most Popular

  • Past Week

    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Inside the grueling life of a surgery intern

      Randall S. Fong, MD | Physician
    • 1 in 5 doctors will become disabled. Are you prepared?

      Amarish Dave, DO | Finance
    • The art of pediatrics: Connecting through observation

      Alexander Rakowsky, MD | Conditions
    • Misinformed claims and the offensiveness of discrediting COVID-19 vaccine development

      Angel Garcia Otano, MD | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
  • Recent Posts

    • The art of pediatrics: Connecting through observation

      Alexander Rakowsky, MD | Conditions
    • Assertiveness in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Epigenetics and our inheritance to future generations

      Vishruth Nagam | Conditions
    • Practicing medicine with conviction

      Arthur Lazarus, MD, MBA | Physician
    • The power of memory in shaping human identity

      Emily F. Peters and Sandeep Jauhar, MD, PhD | Physician
    • How Tratak yoga reshaped my USMLE Step 2 prep

      Dr. Nikita Mehdiratta | Education

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Precision medicine: the rifle vs. shotgun approach to cancer treatment
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...